PVLA Palvella Therapeutics, Inc.

$112.97 +0.39%

Healthcare · Pharmaceutical Preparations

Palvella Therapeutics, Inc. (PVLA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.6 billion. Shares last traded at $112.97, 25.2% below their 52-week high. Over the past year the stock is up 430.9%. Net profit margin is -97.4%, below the peer median of -0.1%. Revenue grew 65.3% year over year.

Market Cap

$1.6B

Shares Out

14.3M

EPS (TTM)

$-6.17

P/E Ratio

—

P/S Ratio

37.85

P/B Ratio

6.97

Dividend / Share

—

Dividend Yield

—

52-Week High

$151.00

52-Week Low

$20.27

Volume

9,590

Avg Vol (3m)

13,384.571

Performance

+6.31%

+3.45%

-0.79%

+16.68%

YTD

+12.49%

+430.87%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

49.86

SMA (50)

$119.13

SMA (200)

$97.75

Price vs SMA50

-5.17%

Price vs SMA200

+15.57%

ATR (14)

$6.30

Financials

Revenue

$43M

Net Income

$-42M

Gross Margin

—

Operating Margin

-90.2%

Net Margin

-97.4%

Return on Equity

-18.0%

Return on Assets

-15.8%

Current Ratio

28.88

Debt / Equity

0.14

Revenue Growth (YoY)

+65.3%

Latest reported annual period ending 2023-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-1.20	2026-05-07
FY 2025	$-3.71	2026-03-31
Q3 2025	$-2.63	2025-11-12
Q2 2025	$-1.60	2025-08-14
Q1 2026	$-0.74	2026-05-07
FY 2025	$-7.83	2026-03-31

Full earnings history →

Pharmaceutical Preparations peers

PVLA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

37.85 / 3.54 med

+970% premium

Net margin vs peers

-97.4% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.